ScholarIQanswers from OpenAlex

Secondary CNS myeloma with remission after systemic CNS-penetrating agents

PaperCitations, authors & open-access status

Secondary CNS myeloma with remission after systemic CNS-penetrating agents is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Secondary CNS myeloma with remission after systemic CNS-penetrating agents have?

ScholarIQcitation count

Secondary CNS myeloma with remission after systemic CNS-penetrating agents has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Secondary CNS myeloma with remission after systemic CNS-penetrating agents published?

ScholarIQyear

Secondary CNS myeloma with remission after systemic CNS-penetrating agents has 2022 year in the ScholarIQ index.

What is the open-access status of Secondary CNS myeloma with remission after systemic CNS-penetrating agents?

ScholarIQoa status

Secondary CNS myeloma with remission after systemic CNS-penetrating agents has gold oa status in the ScholarIQ index.

What is the DOI of Secondary CNS myeloma with remission after systemic CNS-penetrating agents?

ScholarIQdoi

The DOI for Secondary CNS myeloma with remission after systemic CNS-penetrating agents is on the source record.

What is the PMID of Secondary CNS myeloma with remission after systemic CNS-penetrating agents?

ScholarIQpmid

The PMID for Secondary CNS myeloma with remission after systemic CNS-penetrating agents is on the source record.

What is the OpenAlex record for Secondary CNS myeloma with remission after systemic CNS-penetrating agents?

ScholarIQopenalex

The OpenAlex for Secondary CNS myeloma with remission after systemic CNS-penetrating agents is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial